Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• Meaningful measures: Diversifying rheumatology workforce starts with the pipeline Rob Volansky
• Johnson & Johnson halts COVID-19 vaccine trials due to ‘unexplained illness’ Eamon N. Dreisbach
• NIH launches phase 3 trial to test immune modulators for COVID-19 Ken Downey Jr.
• FDA accepts avacopan NDA for ANCA-associated vasculitis Jason Laday
• FDA approves Xeljanz, first JAK inhibitor for polyarticular course JIA Robert Stott
• Looking back and looking ahead: COVID-19 still going strong Leonard H. Calabrese, DO
• FDA approves remdesivir, first treatment for COVID-19 Janel Miller
• Unproven ‘stem cell therapy’ claims spread beyond arthritis into COVID-19 Jason Laday
• Belimumab plus standard therapy superior to standard therapy alone for lupus nephritis Jason Laday
• Combined hydroxychloroquine, azithromycin use increases cardiovascular risk in RA Jason Laday
• COVID-19 outcomes worse in patients with inflammatory arthritis receiving glucocorticoids Jason Laday
• Glucocorticoids boost infection risk among patients with RA receiving DMARDs Jason Laday
• High-intensity physical activity through adolescence helps prevent osteoporosis Jason Laday
• Medicare spending on conventional DMARDs increased fivefold over 5 years Jason Laday
• No single sign, symptom adequate 'to rule in or rule out' giant cell arteritis Jason Laday
• Pegloticase plus methotrexate bested pegloticase alone in uncontrolled gout response Jason Laday
• Smoking status, antimalarial use heavily influence cancer risk in SLE Jason Laday
• Women in academic rheumatology less likely to be full, associate professors Jason Laday
• Clinicians treating PsA may no longer be 'throwing a dart' to choose optimal drug Rob Volansky
• Gout-PsA overlap warrants new look at disease mechanisms, role of urate crystals Robert Stott
• 'Life is not a chemical deficiency': Exploring opioid use in rheumatology practice Rob Volansky
• 'Newer meds' have opened the door for 'newer concepts' in treating RA Rob Volansky
• Targeting bone marrow lesions may reduce osteoarthritis pain Jason Laday
• Lupus Foundation of America: Patients remain 'at the heart of everything we do' Rob Volansky
• Unraveling obesity-related genes may hold clue to RA risk, role of inflammation Rob Volansky
• Baricitinib plus remdesivir improve outcomes for patients with COVID-19 vs. remdesivir alone Madison Weller
• FDA warns of possible fetal risk linked to NSAIDs Robert Stott